Advertisement

Topics

BioSpecifics Technologies Corp. Reports Third Quarter 2017 Financial Results

08:00 EST 10 Nov 2017 | BioMedReports - Blog

"BioSpecifics continues to make important progress as we remain focused on further developing XIAFLEX for the treatment of serious medical conditions. We are excited about

Read more...

Original Article: BioSpecifics Technologies Corp. Reports Third Quarter 2017 Financial Results

NEXT ARTICLE

More From BioPortfolio on "BioSpecifics Technologies Corp. Reports Third Quarter 2017 Financial Results"

Advertisement
Quick Search
Advertisement
Advertisement